First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
基于同种异体和自身免疫肿瘤反应性的个性化免疫治疗疫苗，用于治疗复发性、不完全切除的、难治性胶质母细胞瘤（GBM）肿瘤，其首批临床结果已公布。
期刊:
影响因子:
doi:10.1016/j.vaccine.2015.03.095
Schijns, Virgil E J C; Pretto, Chrystel; Devillers, Laurent; Pierre, Denis; Hofman, Florence M; Chen, Thomas C; Mespouille, Pascal; Hantos, Peter; Glorieux, Philippe; Bota, Daniela A; Stathopoulos, Apostolos
